University of Pennsylvania
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).
University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.
University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,423 total, page 26 of 29
Support for Cardiovascular Health in African American Primary Care Patients
NCT00948714
Biomarkers for Obstructive Sleep Apnea
NCT00834509
Being Responsible for Ourselves HIV Risk Reduction for Black MSM
NCT02561286
Beverage Choice and Lifestyle Modification in Overweight Youth
NCT01662570
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial
NCT00593450
Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
NCT00468208
Genetics of Polycystic Ovary Syndrome
NCT00647335
Treatment of Early Childhood Overweight in Primary Care: Pilot Study
NCT01662557
Message Priming and Enrollment in, and Response to, a Smoking Cessation Program: A Pilot Study
NCT00596882
Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot Study
NCT00523705
Seroquel for Frequent, Heavy Drinkers
NCT00674765
Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression
NCT00641108
The Darbepoetin Alfa for Ischemic Surgical Complications (DISC) Dose Finding Trial
NCT00647998
Safety of Red Yeast Rice for High Cholesterol in Individuals With Statin Intolerance
NCT00639223
Patient-Controlled Sedation Versus Anesthesiologist-Administered Sedation
NCT00868920
Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant
NCT00674427
Chantix for Treating Cocaine Dependence
NCT00567008
Understanding Treatment Response With Naltrexone Among White Alcoholics
NCT00817089
Testing Strategies to Improving Warfarin Adherence
NCT00622102
Antidepressant Therapy in Treating Bipolar Type II Major Depression
NCT00602537
A Study of the Pre- and Post-operative Semen Analyses and Reproductive Hormone Levels of Men Undergoing Weight-reduction Surgery
NCT00596739
Effects of Varenicline on Brain Activity During Nicotine Abstinence
NCT00602927
Multipeptide Vaccine for Advanced Breast Cancer
NCT00573495
Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)
NCT00633945
Childhood Adenotonsillectomy Study for Children With OSAS
NCT00560859
An In-Hospital Family Member Cardiopulmonary Resuscitation (CPR) Education Program
NCT01260441
Assessment of a Teachable Moment for Smoking Cessation
NCT00596440
Biosynthesis of PGD2 in Vivo
NCT01275300
Use and Harm Exposure in New Low Nicotine Cigarettes
NCT01202942
Cytomegalovirus (CMV) Infection in Amniotic Fluid
NCT00194142
TMS in Aphasia Recovery
NCT04777214
Ovarian Freezing Before Cancer Treatment
NCT01057745
Evaluating the Effectiveness of Financial Incentives in Promoting Weight Loss Among Obese Individuals.
NCT00520611
The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study
NCT00953667
Effectiveness of Extended Treatments for Drug Dependence
NCT00685659
The Longitudinal Ovarian Reserve Study
NCT02395341
Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser
NCT00523588
Ghrelin in Healthy and Frail Older Women
NCT00520884
Improving Metoclopramide Prescribing Practices at Penn Through a Physician-targeted Intervention
NCT01126034
Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients
NCT00522548
Advance Supply of Emergency Contraception Compared to Routine Postpartum Care in Teens
NCT00433004
Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant
NCT00434629
Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals
NCT00428519
Phase I/II Clinical Trial Combining hTERT Tumor Vaccine & Autologous T Cells in Patients With Advanced Myeloma
NCT00834665
A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation
NCT00408200
Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence
NCT00385268
Patient Feedback Effectiveness Study
NCT00798044
Combined Treatment for Generalized Anxiety Disorder (GAD)
NCT00620776
Efficacy of Different Ablation Strategies for Controlling Atrial Fibrillation
NCT00379301
HIV and STD Prevention for High-Risk, Inner-City, African American Youth
NCT00353405
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 182 |
| Phase 2 | 157 |
| Phase 3 | 43 |
| Phase 4 | 87 |
Therapeutic Areas
What is open in the University of Pennsylvania pipeline
199 recruiting of 1,423 indexed (14% open); 982 completed (69%).
Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.